NASDAQ:IVVD - Nasdaq - US00534A1025 - Common Stock - Currency: USD
Overall IVVD gets a fundamental rating of 3 out of 10. We evaluated IVVD against 561 industry peers in the Biotechnology industry. While IVVD seems to be doing ok healthwise, there are quite some concerns on its profitability. IVVD has a correct valuation and a medium growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -131.2% | ||
ROE | -251.59% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 93.63% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | -12.8 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.62 | ||
Quick Ratio | 1.62 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | 0.92 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
0.8092
+0.03 (+4.33%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | 0.92 | ||
P/S | 3.82 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 1.44 | ||
P/tB | 1.44 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -131.2% | ||
ROE | -251.59% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 93.63% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 4.5% | ||
Cap/Sales | 0.55% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 1.62 | ||
Quick Ratio | 1.62 | ||
Altman-Z | -12.8 |